My dad, Fred, was fit and self-reliant his whole life. In early 2025, pancreatic cancer took that from him within weeks.
By the end, he had lost control of his bowels, and the only thing anyone could offer him was a nappy. His skin broke down from sitting in his own faeces. My mum, Ruth, his primary carer, changed him around the clock, distressed and exhausted. He died in March 2025. None of us were prepared for how much dignity, and how much care, that would cost.
This isn’t only our story. The same quiet crisis is happening in homes, care homes and hospital wards across the country, to people who will never raise it with their GP, let alone their MP. I started Joyvié Health because dignity should never depend on whatever happens to be on the shelf.

Unseen, and badly counted
Ask how many UK adults live with faecal incontinence and you’ll get two very different answers. NHS England’s 2018 estimate, quoted by the House of Commons Library, is just over half a million, against 14 million with urinary incontinence. NICE puts it at up to 10 per cent of adults: more than five million people.
Same condition. Counted two ways. One assumes people tell someone. The other assumes most won’t.
Most won’t. It’s hard to say out loud and hard to describe to a GP. And the relatives doing the caring are usually too embarrassed, too exhausted or too short of time to raise it. The House of Commons Library confirmed this year that there is no centrally collected official data on how many patients have continence care needs.
Faecal incontinence is subjective and chronically underreported. We’ve never truly understood the scale of the problem because people are too ashamed to tell us. What Joyvié is building helps address the unmet clinical need.
Dr Ashish Sinha, consultant colorectal surgeon at St Mark’s and clinical adviser to Joyvié Health
Parliament has started to notice the wider issue. In June, an early day motion signed by eight MPs from three parties called on the Government to end the rationing of continence pads. It’s a welcome step. But it’s framed around urinary incontinence, and the harms it names are skin and urinary tract infections. Faecal incontinence isn’t mentioned once.
That’s not a dig at the MPs who signed it. It’s the exact pattern I’m describing, playing out in real time.
A design failure, not a care failure
Pads for faecal incontinence are built on one idea: seal stool against the skin and hope for the best.
Hope belongs to families, not to product design.
Trapped moisture, enzymes and shifting pH break skin down. The result is incontinence-associated dermatitis (IAD). A large prevalence survey (Kayser et al., 2019) found it in 26 per cent of patients using faecal containment, more than double the rate for urinary incontinence.
There’s a second cost, and it’s harder to see. A care home told us that when stool touches skin, residents can become distressed, sometimes aggressive. The carer absorbs all of it while cleaning skin and sheets. That’s in a workforce the Health Foundation, Nuffield Trust and King’s Fund expect to stay short-staffed for years.
None of this is the fault of nurses or carers. It’s product design, quietly accepted because it serves the condition people least want to talk about.
Enough.
What we’re building, and what it can’t fix alone
At Joyvié Health we’re developing underwear that contains stool and keeps it off the skin. It’s designed to restore dignity, maintain skin integrity and free up more time for care.
We’re still early. Formative studies are underway, and we’re backed by Innovate UK, the NHS Clinical Entrepreneur Programme and the LIHE MedTech Venture Builder at King’s College London. Dawn wore an early version for four days and nights in one of those studies. She put it better than I can: “First time I’ve ever worn anything, and I’ve not had an accident, put it that way.”
But a better product is only half of it. A system that doesn’t name faecal incontinence as its own category has no reason to fund it, measure it or reward anyone for getting it right.
Two levers that already exist
The Better Care Fund is the £9.15 billion budget NHS England and local government use to fund integrated care. Preventing avoidable long-term care home admissions is one of its named conditions (BCF Framework 2026 to 2027). Every integrated care board had to submit an assurance return in May confirming that unpaid carers are systematically identified and offered carer’s assessments and respite. That’s the exact support my mum never got.

Nowhere in the framework is continence named as a driver of admission. That isn’t evidence it doesn’t matter. It’s evidence nobody has been asked to check.
Value Based Procurement is the second lever. DHSC guidance published in June caps whole-life cost at 40 per cent of a medtech tender score, and weighs the rest against outcomes for patients. That lets continence products, ours included, compete on what they deliver, not just on what they cost. Between the two, a trust now has a reason and a route to buy differently. But only if faecal incontinence is named clearly enough to be seen.
The pattern holds even where someone has looked. A 2022 national study of pathways into care homes (UnPiCD, Age and Ageing) found incontinence recorded in just 3.8 per cent of admissions. Not because it’s rare, but because routine records barely capture it. The last direct look I can find was Oxfordshire County Council in 2010, sixteen years ago. Faecal incontinence appeared in over a third of admissions there, folded in with other factors and never counted on its own.
A condition nobody counts on its own terms can’t be designed for, funded or protected against. My mum felt that gap long before I had the words for it.
It’s cheaper, and kinder, to act earlier. Faecal incontinence is a specific place to start, inside a fund that already exists to stop the admissions it causes.
What I’m asking for
If you’re an MP, a commissioner or you sit on an ICB, there’s one thing you can do this week. The BCF assurance return already exists. Ask whether faecal incontinence featured in it, and whether the carers managing it were identified. If the answer is silence, that tells you something: a fund built to prevent avoidable admissions may have no way of seeing one of the conditions driving them.
Two further changes would widen that opening, and neither needs new money. Name faecal incontinence explicitly in the Better Care Fund’s own reporting. And name it in Value Based Procurement’s outcome criteria too.
Dignity in continence care isn’t a nice-to-have, sitting beside genomics and AI in the innovation conversation. It’s the baseline. And right now, people living with faecal incontinence, and the people caring for them, are going without it, behind closed doors, in a category too ashamed to speak up for itself.
None of this changes what happened to Mum and Dad. But if these asks are met honestly, the next family facing what we faced gets a system that’s actually looking.
The better option Fred and Ruth never had.
If you can make one of these asks, or you know who can, my DMs are open.
Sources
- House of Commons Library, Bladder and bowel continence care, debate pack CDP-2023-0145, updated 8 July 2026
- NICE (2007) Faecal incontinence in adults: management, CG49
- UK Parliament, Early Day Motion 216, tabled 1 June 2026
- Kayser S.A. et al. (2019) Journal of Wound, Ostomy and Continence Nursing 46(4): 285 to 290
- Health Foundation, Nuffield Trust and King’s Fund (2019) Closing the gap
- DHSC, MHCLG and NHS England (2026) Better Care Fund Framework 2026 to 2027
- DHSC (2026) Value Based Procurement National Standard Guidance for Medical Technology
- UnPiCD study (2022), Age and Ageing 51(12), afac304
- Taylor R., Cairncross L. and Livadeas S. (2010) Research, Policy and Planning 28(2): 91 to 102